
Smith & Nephew plc SNN
€ 28.27
1.4%
Geschäftsbericht 2025
hinzugefügt 04.04.2026
Smith & Nephew plc Finanzkreislauf 2011-2026 | SNN
Finanzkreislauf Jährlich Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 125 | 131 | 117 | 84.6 | 87 | 94.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 131 | 84.6 | 107 |
Finanzkreislauf anderer Aktien in der Medizinische Geräte
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Butterfly Network
BFLY
|
815 | $ 4.15 | 0.97 % | $ 878 M | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
227 | $ 36.68 | -0.22 % | $ 5.46 K | ||
|
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | ||
|
Boston Scientific Corporation
BSX
|
107 | $ 62.35 | -0.75 % | $ 92.3 B | ||
|
AxoGen
AXGN
|
245 | $ 32.46 | -5.75 % | $ 1.49 B | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
137 | $ 171.5 | 0.53 % | $ 12.8 B | ||
|
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | ||
|
Alphatec Holdings
ATEC
|
240 | $ 10.88 | 0.46 % | $ 1.63 B | ||
|
TELA Bio
TELA
|
185 | $ 0.62 | 3.21 % | $ 29.1 M | ||
|
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | ||
|
ClearPoint Neuro
CLPT
|
217 | $ 9.37 | - | $ 265 M | ||
|
CONMED Corporation
CNMD
|
212 | $ 33.91 | -2.53 % | $ 1.05 B | ||
|
Cytosorbents Corporation
CTSO
|
104 | $ 0.61 | 3.77 % | $ 38 M | ||
|
Delcath Systems
DCTH
|
258 | $ 9.71 | 0.83 % | $ 348 M | ||
|
EDAP TMS S.A.
EDAP
|
136 | $ 3.51 | 3.39 % | $ 131 M | ||
|
Edwards Lifesciences Corporation
EW
|
283 | $ 80.85 | -0.25 % | $ 47.3 B | ||
|
FONAR Corporation
FONR
|
234 | $ 18.59 | -0.01 % | $ 122 M | ||
|
Electromed
ELMD
|
180 | $ 23.43 | 0.6 % | $ 198 M | ||
|
Helius Medical Technologies
HSDT
|
18.2 | $ 1.91 | 2.69 % | $ 1.16 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 9.22 | -3.27 % | $ 710 M | ||
|
Globus Medical
GMED
|
314 | $ 88.19 | 0.31 % | $ 11.9 B | ||
|
Inogen
INGN
|
48.9 | $ 6.36 | 2.42 % | $ 169 M | ||
|
IRIDEX Corporation
IRIX
|
105 | $ 1.01 | 3.06 % | $ 17.1 M | ||
|
IRadimed Corporation
IRMD
|
224 | $ 95.62 | -0.63 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
96.8 | $ 85.67 | -1.36 % | $ 2.98 B | ||
|
NanoVibronix
NAOV
|
853 | - | - | $ 1.08 M |